Nexviazyme 100 mg/10mL
avalglucosidase alfa-ngpt · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Genzyme Corporation
Nexviazyme is a injection, powder, lyophilized, for solution containing avalglucosidase alfa-ngpt at 100 mg/10mL, taken intravenous. Manufactured by Genzyme Corporation.
Key Facts
- Brand Name
- Nexviazyme
- Generic Name
- avalglucosidase alfa-ngpt
- NDC Code (Product)
58468-0426- Manufacturer
- Genzyme Corporation
- Strength
- 100 mg/10mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761194
- Drug Class
- Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]
- Marketing Start
- 08/06/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Nexviazyme used for?
Nexviazyme contains avalglucosidase alfa-ngpt. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Nexviazyme a controlled substance?
Nexviazyme is not classified as a controlled substance by the DEA.
What is the generic name for Nexviazyme?
The generic name for Nexviazyme is avalglucosidase alfa-ngpt. There are no other listed brand versions of avalglucosidase alfa-ngpt.
What is the NDC code for Nexviazyme 100 mg/10mL?
The NDC (National Drug Code) for Nexviazyme 100 mg/10mL is 58468-0426, listed by Genzyme Corporation.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)